A Hims & Hers commercial promoting compounded weight loss drugs in this year’s Super Bowl is spurring concerns from industry watchers over how the FDA regulates the gray area of advertising copycat products.
The growing telehealth company is set to air a minute-long commercial Sunday night that promotes the use of its compounded version of
The ad—previewed days before the game between the Philadelphia Eagles and the Kansas City Chiefs that’s expected bring in over 100 million viewers—criticizes the health industry for high costs of weight loss drugs, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.